Ligand validation:2HVI

DCT: 2',3'-DIDEOXYCYTIDINE 5'-TRIPHOSPHATE

DCT is a Ligand Of Interest in 2HVI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2HVI_DCT_A_201	83%	36%	0.105	0.963	1.2	1.31	2	5	2	0	100%	1
2HVI_DCT_D_202	72%	36%	0.149	0.973	1.21	1.32	2	5	2	0	100%	1
2HVI_DCT_A_203	17%	34%	0.228	0.802	1.2	1.39	2	4	4	0	100%	1
3PX6_DCT_D_202	95%	36%	0.085	0.987	0.93	1.57	1	9	2	0	100%	1
4DQP_DCT_D_901	94%	39%	0.091	0.991	0.94	1.43	1	4	0	0	100%	1
3PX4_DCT_D_202	92%	50%	0.08	0.969	0.8	1.11	-	1	1	0	100%	1
2HVH_DCT_D_881	86%	33%	0.11	0.979	1.51	1.17	3	2	6	0	100%	1
4N5S_DCT_A_907	96%	48%	0.077	0.987	0.81	1.2	-	2	0	0	100%	1
4BWJ_DCT_A_1833	94%	6%	0.068	0.965	2.61	2.56	8	7	0	0	100%	1
4QZB_DCT_A_603	92%	30%	0.092	0.985	1.33	1.46	5	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.